Carisma Therapeutics, Inc.

Historical 13F Holders

Symbol
CARM
CUSIP
14216R101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 14216R101 since 12/18/2024, newest first.

Filer % of Class Filed
HealthCap VII, L.P. 13D/A Amendment 6
0% 9/2/2025
Event 9/2/2025
HealthCap VII, L.P. 13D/A Amendment 5
4.8% 8/29/2025
Event 8/27/2025
HealthCap VII, L.P. 13D/A Amendment 4
6.5% 8/21/2025
Event 8/19/2025
AbbVie Biotechnology Ltd 13G/A Amendment 1 4.4% 4/25/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 2 985 $0
2026 Q2 1 785 $4
2026 Q1 3 1.47 M $47.9k
2025 Q4 7 1.57 M $67.0k
2025 Q3 34 3.12 M $854k
2025 Q2 38 4.02 M $1.57M
2025 Q1 39 5.61 M $1.74M
2024 Q4 43 5.66 M $2.37M
2024 Q3 39 5.24 M $5.14M
2024 Q2 55 6.11 M $7.38M
2024 Q1 52 8.51 M $19.3M
2023 Q4 53 9.00 M $22.7M
2023 Q3 61 9.37 M $32.2M
2023 Q2 55 9.58 M $84.0M
2023 Q1 39 5.57 M $10.5M